Less chemo after surgery for low-risk stomach or esophagus cancer
Part of Cancer, Digestive system clinical trials.
This trial compares a shorter course of chemo to the standard longer course after surgery, for people whose cancer was caught early and responded well to pre-surgery chemo. It aims to see if reducing chemo after surgery is just as effective with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have stomach, esophagus, or gastroesophageal junction cancer that has not spread to other parts of the body.
- You have already completed at least 4 rounds of a specific chemo (FLOT) before surgery, and your surgery completely removed the tumor with clear margins.
- After surgery, the cancer shows low risk of coming back (no cancer in lymph nodes and limited tumor depth).
- You are fit enough to receive more chemo after surgery and have adequate organ function (kidney, liver, blood counts).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people who have already had chemotherapy and surgery for stomach cancer. It compares different follow-up approaches to see if skipping more chemo after surgery is safe and effective.
This trial studies which surgical approach (removing lymph nodes in a more limited vs more extensive way) works best for gastric cancer after you’ve already started chemotherapy before surgery. It’s aimed at improving cancer control while keeping the operation as safe as possible.
This trial compares two approaches after surgery for early-stage stomach or GEJ cancer: close monitoring (follow-up) vs. adjuvant chemotherapy (chemo given after surgery). It aims to see if follow-up alone is as good as chemo for patients with this stage, potentially avoiding chemo side effects.
This trial tests a shorter course of radiation combined with chemotherapy (FOLFOX) before surgery for esophageal or stomach-junction cancer. It aims to reduce side effects and still improve outcomes.
This study tests whether adding radiation or surgery to chemotherapy can improve outcomes for people whose esophageal or stomach cancer has spread to only a few places. If your cancer is “oligometastatic” (up to 3 spots), the trial helps doctors see which approach gives the best control.
This trial tests a minimally invasive surgery for stomach cancer that has spread to lymph nodes near the main blood vessels (para-aortic area). The surgery is done after a combination of chemotherapy and immunotherapy to shrink the tumor. It aims to see if this approach is safe and effective.
Hear when a new Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.